Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD.

Takefumi Kimura Naoki TanakaNaoyuki FujimoriTomoo YamazakiTakahito KatsuyamaYuichi IwashitaJonathan PhamSatoru JoshitaSai P PydiTakeji Umemura

Published in: Liver international : official journal of the International Association for the Study of the Liver (2021)

Serum TSP2 levels reflected hepatocyte ballooning, fibrosis and NAS in NAFLD patients. For clinical application of serum TSP2 as a predictor of NAFLD histological activity, additional validation and mechanistic investigations are required.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
liver injury
patient reported outcomes
drug induced